News and articles related to topics including Global Infectious Diseases: Prevention, Preparedness and Response and the China-US Relations conference.
With nine million new cases appearing every year, tuberculosis (TB) is far from a disease of the past. We sat down with Jeffrey Cirillo, Ph.D., professor at the Texas A&M Health Science Center College of Medicine, who has spent the last 28 years researching tuberculosis, to find out more about one of the world’s deadliest infectious diseases.
The influenza pandemic of 2009 and more recent threats involving Middle East Respiratory Syndrome (MERS) and Ebola revealed national preparedness gaps, a topic explored extensively at the George H.W. Bush Sixth China-U.S. Relations Conference in Houston. Remedies are essential to avoid future high-consequence emergencies that could threaten large segments of our populations, economies and infrastructure.
Public health threats know no boundaries, and global security depends upon preparedness and collaboration in establishing sustainable public health systems around the world, said a panel of high-ranking experts at the George H.W. Bush Sixth China-U.S. Relations Conference hosted by Texas A&M Health Science Center in Houston.
The social media hashtag #EndPandemics tied to this week’s 6th George H.W. Bush China-U.S. Relations Conference in Houston is more than a memorable phrase. It is indeed a specific objective — one that could be accomplished within the next decade, if there is bold and focused American leadership accompanied by strong international cooperation and transparent sharing of data.
A critical challenge in the TB fight is the reality that the disease hits citizens hardest in areas with the least resources to fight it. Participants at the George H.W. Bush Sixth China-U.S. Relations Conference in Houston are intent on solving this global challenge with advancements in diagnosis and treatment that can potentially benefit all the world’s citizens.
For decades, the U.S. and China have collaborated on international health issues, and the timing has never been more pivotal to take that partnership to the next level, Centers for Disease Control and Prevention Director Tom Frieden, M.D., M.P.H., told an audience of the world’s most elite physicians, scientists, policymakers, government officials and business leaders during the China-U.S. Relations Conference keynote address on May 12.
International collaboration and innovative partnerships with industry, government, speeding bench-to-bedside discoveries
Whether it’s an inhaled therapeutic that stimulates innate immunity of the lungs to prevent the spread of bacterial and viral infections, or a novel tuberculosis test that allows doctors to diagnose the infectious disease within minutes, the partnerships between academic institutions, their spinoff companies, industry, and government are the driving force behind advancing these products to the market — and on faster timelines than ever before.